These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 10554796)

  • 41. Significance of myeloid antigen expression in precursor T lymphoblastic lymphoma.
    Cai Y; Sun XF; Yan SL; Zhen ZJ; Xia Y; Ling JY
    Chin J Cancer; 2010 Mar; 29(3):312-6. PubMed ID: 20193116
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Induction of apoptosis and bcl-2 expression in acute lymphoblastic leukaemia and non-Hodgkin's lymphoma in children.
    Pituch-Noworolska A; Hajto B; Balwierz W; Klus K
    Haematologia (Budap); 2001; 31(3):191-207. PubMed ID: 11855781
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Increased expression of myeloid antigen markers in adult acute lymphoblastic leukaemia patients: diagnostic and prognostic implications.
    Lauria F; Raspadori D; Martinelli G; Rondelli D; Ventura MA; Farabegoli P; Tosi P; Testoni N; Visani G; Zaccaria A
    Br J Haematol; 1994 Jun; 87(2):286-92. PubMed ID: 7947269
    [TBL] [Abstract][Full Text] [Related]  

  • 44. P-glycoprotein and multidrug resistance-associated protein, but not lung resistance protein, lower the intracellular daunorubicin accumulation in acute myeloid leukaemic cells.
    Borg AG; Burgess R; Green LM; Scheper RJ; Liu Yin JA
    Br J Haematol; 2000 Jan; 108(1):48-54. PubMed ID: 10651723
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The cytotoxic effects of gemtuzumab ozogamicin (mylotarg) in combination with conventional antileukemic agents by isobologram analysis in vitro.
    Tanaka M; Kano Y; Akutsu M; Tsunoda S; Izumi T; Yazawa Y; Miyawaki S; Mano H; Furukawa Y
    Anticancer Res; 2009 Nov; 29(11):4589-96. PubMed ID: 20032408
    [TBL] [Abstract][Full Text] [Related]  

  • 46. An etoposide-resistant lung cancer subline overexpresses the multidrug resistance-associated protein.
    Doyle LA; Ross DD; Ordonez JV; Yang W; Gao Y; Tong Y; Belani CP; Gutheil JC
    Br J Cancer; 1995 Sep; 72(3):535-42. PubMed ID: 7669558
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Relation of cellular drug resistance to long-term clinical outcome in childhood acute lymphoblastic leukaemia.
    Pieters R; Huismans DR; Loonen AH; Hählen K; van der Does-van den Berg A; van Wering ER; Veerman AJ
    Lancet; 1991 Aug; 338(8764):399-403. PubMed ID: 1678081
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cytosine arabinoside (ara-C) resistance confers cross-resistance or collateral sensitivity to other classes of anti-leukemic drugs.
    Martin-Aragon S; Mukherjee SK; Taylor BJ; Ivy SP; Fu CH; Ardi VC; Avramis VI
    Anticancer Res; 2000; 20(1A):139-50. PubMed ID: 10769646
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Inhibition of the P-glycoprotein- and multidrug resistance protein-mediated efflux of anthracyclines and calceinacetoxymethyl ester by PAK-104P.
    Marbeuf-Gueye C; Salerno M; Quidu P; Garnier-Suillerot A
    Eur J Pharmacol; 2000 Mar; 391(3):207-16. PubMed ID: 10729360
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Favorable prognosis of hyperdiploid common acute lymphoblastic leukemia may be explained by sensitivity to antimetabolites and other drugs: results of an in vitro study.
    Kaspers GJ; Smets LA; Pieters R; Van Zantwijk CH; Van Wering ER; Veerman AJ
    Blood; 1995 Feb; 85(3):751-6. PubMed ID: 7833478
    [TBL] [Abstract][Full Text] [Related]  

  • 51. High Expression of Lung Resistance Protein mRNA at Diagnosis Predicts Poor Early Response to Induction Chemotherapy in Childhood Acute Lymphoblastic Leukemia.
    Bhatia P; Masih S; Varma N; Bansal D; Trehan A
    Asian Pac J Cancer Prev; 2015; 16(15):6663-8. PubMed ID: 26434891
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Diverse effects of P-glycoprotein inhibitory agents on human leukemia cells expressing the multidrug resistance protein (MRP).
    Lehne G; Mørkrid L; den Boer M; Rugstad HE
    Int J Clin Pharmacol Ther; 2000 Apr; 38(4):187-95. PubMed ID: 10783828
    [TBL] [Abstract][Full Text] [Related]  

  • 53. CD33+ B-cell precursor acute lymphoblastic leukemia in children: a distinct subgroup of B-cell precursor acute lymphoblastic leukemia.
    Hara J; Hosoi G; Okamura T; Osugi Y; Ishihara S; Yumura-Yagi K; Kawa-Ha K; Tawa A
    Int J Hematol; 1995 Feb; 61(2):77-84. PubMed ID: 7734715
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Drug-resistance Profile in Multiple-relapsed Childhood Acute Lymphoblastic Leukemia.
    Pogorzala M; Kubicka M; Rafinska B; Wysocki M; Styczynski J
    Anticancer Res; 2015 Oct; 35(10):5667-70. PubMed ID: 26408741
    [TBL] [Abstract][Full Text] [Related]  

  • 55. In vitro susceptibility to dexamethasone- and doxorubicin-induced apoptotic cell death in context of maturation stage, responsiveness to interleukin 7, and early cytoreduction in vivo in childhood T-cell acute lymphoblastic leukemia.
    Wuchter C; Ruppert V; Schrappe M; Dörken B; Ludwig WD; Karawajew L
    Blood; 2002 Jun; 99(11):4109-15. PubMed ID: 12010814
    [TBL] [Abstract][Full Text] [Related]  

  • 56. In vitro cellular drug resistance in children with relapsed/refractory acute lymphoblastic leukemia.
    Klumper E; Pieters R; Veerman AJ; Huismans DR; Loonen AH; Hählen K; Kaspers GJ; van Wering ER; Hartmann R; Henze G
    Blood; 1995 Nov; 86(10):3861-8. PubMed ID: 7579354
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The relationship between modulation of MDR and glutathione in MRP-overexpressing human leukemia cells.
    Grech KV; Davey RA; Davey MW
    Biochem Pharmacol; 1998 Apr; 55(8):1283-9. PubMed ID: 9719484
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Anticancer drug-mediated induction of multidrug resistance-associated genes and protein kinase C isozymes in the T-lymphoblastoid cell line CCRF-CEM and in blasts from patients with acute lymphoblastic leukemias.
    Beck JF; Brügger D; Brischwein K; Liu C; Bader P; Niethammer D; Gekeler V
    Jpn J Cancer Res; 2001 Aug; 92(8):896-903. PubMed ID: 11509123
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Double knockout of the MRP gene leads to increased drug sensitivity in vitro.
    Lorico A; Rappa G; Flavell RA; Sartorelli AC
    Cancer Res; 1996 Dec; 56(23):5351-5. PubMed ID: 8968083
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A subset of acute lymphoblastic leukemia with co-expression of myeloid antigens: prevalence and clinical significance.
    Hsu PN; Tien HF; Wang CH; Chen YC; Shen MC; Lin DT; Lin KH; Liang DC; Lin KS
    J Formos Med Assoc; 1991 Mar; 90(3):225-31. PubMed ID: 1677396
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.